公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2000 | Retinoic Acid-Induced Apoptotic Pathway in T-Cell Lymphmoa : Identification of Four Groups of Genes with Differential Biological Function | WANG, KAO-CHUNG; CHENG, ANN-LII; CHUANG, SHUANG-EN; HSU, HEY-CHI; SU, IH-JEN; 鄭安理 | EXPERIMENTAL HEMATOLOGY | | | |
2005 | Significant Difference in the Trends of Female Breast Cancer Incidence between Taiwanese and Caucasian Americans: Implications from Age-Period- Cohort Analysis | SHEN, YING-CHUN; CHANG, CHEE-JEN; HSU, CHIUN; CHENG, ANN-LII | CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION v.14 n.8 pp.1986-1990 | | | |
2008 | Sorafenib Is Effective in Patients from the Asia-Pacific Region with Hepatocellular Carcinoma (Hcc) Subgroup Analysis of Effect of Macroscopic Vascular Invasion, Extrahepatic Spread, and Ecog Performance Status on Outcome | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | HEPATOLOGY | | | |
2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemonaive NSCLC patients receiving first-line gefitinib monotherapy | Yang, Chih-Hsin; Yu, Chong-Jen; Shih, Jin-Yuan; Chang, Yeun-Chung; Hu, Fu-Chang; Tsai, Meng-Chin; Chen, Kuan-Yu; Lin, Zhong-Zhe; Huang, Ching-Ju; Shun, Chia-Tung; Huang, Chin-Lun; Bean, James; Cheng, Ann-Lii; Pao, William; Yang, Pan-Chyr | J Clin Oncol | | | |
2003 | Steroid-Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv-Carriers with Lymphoma | CHENG, ANN-LII; SU, IH-JEN; TIEN, HWEI- FANG; 鄭安理 | HEPATOLOGY | | | |
2003 | Steroid-Tree Chemotherapy Decreases Hepatitis B Virus (Hbv) Reactivation in Hbv-Carrier Lymphoma Patients | CHENG, ANN-LII; HSIUNG, CHAO A.; SU, IH-JEN; CHEN, PEI-JER; CHANG, MING-CHIH; TSAO, CHAO-JUNG; KAO, WOEI-YAU; UEN, WU-CHING; HSU, CHIH-HUNG; TIEN, HWEI-FANG; CHAO, TSU -YI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE; 鄭安理; 陳培哲 | HEPATOLOGY | | | |
2007 | Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinorna Cells Expressing Axl | LAY, JONG-DING; HUANG, JHY-SHRIAN; LAI, GI-MING; CHENG, ANN-LII; SU, IH-JEN; CHUANG, SHUANG-EN; 鄭安理 | CANCER RESEARCH | | | |
1993 | Test Dose Guided Rapid IV Suramine Infusions with Weekly IV Maintenance Doses | Arzoomanian, R.; Rago, R.; Cheng, Ann-Lii; Tombes, M. B.; Alberti, D.; Tusch, K.; Mutch, R.; 鄭安理 | Proceedings:Annual Meeting of the American Society of Clinical Oncology | | | |
2015 | The use of opioids not recommended in guidelines in Taiwan cancer patients. | Hsiue, Han-Chung Emily; Lin, Chih-Peng; Lin, Wen-Ying; Chen, Ho-Min; Cheng, Ann-Lii; Lai, Mei-Shu; Shao, Yu Yun | J. Clin. Oncol. | | | |
2015 | The use of opioids not recommended in guidelines in Taiwan cancer patients. | Hsiue, Han-Chung Emily; Lin, Chih-Peng; Lin, Wen-Ying; Chen, Ho-Min; Cheng, Ann-Lii; Lai, Mei-Shu; Shao, Yu Yun | J. Clin. Oncol. | | | |
2015 | The use of opioids not recommended in guidelines in Taiwan cancer patients. | Hsiue, Han-Chung Emily; Lin, Chih-Peng; Lin, Wen-Ying; Chen, Ho-Min; Cheng, Ann-Lii; Lai, Mei-Shu; Shao, Yu Yun | J. Clin. Oncol. | | | |
2015 | Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model | Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Chiang, Bor-Luen; Lee, Xiao-yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
2012 | Transforming growth factor-beta mediated epithelial to mesenchymal transition contributes to in vivo resistance to sorafenib in hepatocellular carcinoma | Lin, Shiou-Der; Lin, Tzu-Hsuan; Feng, Wen-Chi; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung | Cancer Res. | 0 | 0 | |
2013 | Unique histopathologic features of brain metastases from hepatocellular carcinoma | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii | Journal of Clinical Oncology | 0 | 0 | |
2013 | Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Chang, Yung-Ling; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
1994 | Weekly 24-Hour Infusion with High-Dose 5 Fluorouracil Plus Leucovorin (HDFL) in Metastatic Colorectal Carcinoma | Cheng, Ann-Lii; Lin, M. T.; Wang, C. Y.; Wang, C. H.; Chen, Yee-Chun; Yeh, K. H.; 鄭安理 | Annual Meeting of Chinese Oncology Society | | | |
2006 | Weekly Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (P-HDFL) for Metastatic Urothelial Carcinoma --- An Effective Regimen with Low Toxicity | Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Chen, Jun; Vogelzang, Nicholas J.; Pu, Yeong-Shiau | Cancer | | | |
2007 | Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial | Lin, Chia-Chi; Hsu, Chih-Hung; Hour, Tzyh-Chyuan; Cheng, Ann-Lii; Huang, Chao-Yuan; Huang, Kuo-How; Chen, Jun; Pu, Yeong-Shiau | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung | Cancer Res. | | | |